Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). Their discovery helps define the effects of one of the newest drugs under investigation for treating MS - daclizumab - and could lead to a new class of drugs for treating MS and other autoimmune disorders. In these disorders, the immune system turns against the body's own tissues...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment